WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
Your view on WUXIF
Overview
What the company does, where it operates, and who runs it.
About WuXi AppTec Co., Ltd.
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Ge Li
- Headquarters
- 288 Fute Zhong Road, Shanghai, CN
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Ge Li
- Headquarters
- 288 Fute Zhong Road, Shanghai, CN
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally.
The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others.
It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic.
The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for WuXi AppTec Co., Ltd., and the rating behind it. WUXIF last traded at $13.88, 20.0× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for WuXi AppTec Co., Ltd.. Starting points for WuXi AppTec Co., Ltd.: P/E 20.0, EPS $7.45, beta 0.62 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for WuXi AppTec Co., Ltd.. WuXi AppTec Co., Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for WuXi AppTec Co., Ltd.. Trailing twelve-month EPS for WuXi AppTec Co., Ltd. stands at $7.45. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for WuXi AppTec Co., Ltd.. WuXi AppTec Co., Ltd. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
WuXi AppTec Co., Ltd. valued side by side against its closest peers. WuXi AppTec Co., Ltd. is measured against Medical - Diagnostics & Research peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold WuXi AppTec Co., Ltd., and how their positions are changing. At a $39.77B market value, institutional positions materially move WuXi AppTec Co., Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by WuXi AppTec Co., Ltd. executives and directors. Shares of WuXi AppTec Co., Ltd. have traded between $7.34 and $16.80 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming WuXi AppTec Co., Ltd.. WuXi AppTec Co., Ltd. is a $39.77B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming WuXi AppTec Co., Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for WuXi AppTec Co., Ltd.. Coverage tracks WuXi AppTec Co., Ltd. within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.